Table 4 The stratified analysis for association between HbA1c and Barthel score in complex chronic patients
Covariates | Barthel score | |
|---|---|---|
β (95% CI) | P value | |
Dementia cognitive impairment | ||
Yes | 1.0 (0.2, 1.8) | 0.015 |
No | 0.8 (0.4, 1.2) | < 0.001 |
Diabetes | ||
Yes | 0.8 (-0.4, 2.0) | 0.197 |
No | 0.3 (-0.1, 0.7) | 0.151 |
Atrial fibrillation | ||
Yes | 0.4 (-0.4, 1.2) | 0.301 |
No | 1.0 (0.6, 1.3) | < 0.001 |
Hipercholesterolemia | ||
Yes | 0.7 (0.2, 1.2) | 0.008 |
No | 0.9 (0.4, 1.3) | < 0.001 |
Ischemic cardiomyopathy | ||
Yes | 1.8 (0.8, 2.9) | < 0.001 |
No | 0.7 (0.3, 1.0) | < 0.001 |
Peripheral vascular disease | ||
Yes | 1.3 (-0.3, 2.9) | 0.113 |
No | 0.8 (0.4, 1.1) | < 0.001 |
Heart failure | ||
Yes | 0.3 (-0.5, 1.1) | 0.467 |
No | 0.9 (0.5, 1.3) | < 0.001 |
Thromboembolism | ||
Yes | 1.4 (-0.0, 2.8) | 0.055 |
No | 0.8 (0.5, 1.2) | < 0.001 |
Stroke or TIA | ||
Yes | 0.9 (-0.6, 2.3) | 0.234 |
No | 0.8 (0.5, 1.2) | < 0.001 |
Chronic renal disease | ||
Yes | 0.4 (-0.2, 1.0) | 0.194 |
No | 1.0 (0.6, 1.4) | < 0.001 |
Chronic liver disease | ||
Yes | NA | NA |
No | 0.9 (0.5, 1.2) | < 0.001 |
Oral anticoagulant treatment | ||
Yes | 1.0 (0.3, 1.8) | 0.008 |
No | 0.9 (0.5, 1.2) | < 0.001 |
Nonsteroidal antiinflammatory drugs | ||
Yes | 0.9 (0.5, 1.3) | < 0.001 |
No | 0.5 (-0.3, 1.3) | 0.241 |
Antiaggregants | ||
Yes | 1.2 (0.6, 1.8) | < 0.001 |
No | 0.6 (0.2, 1.0) | 0.007 |
Statines | ||
Yes | 0.7 (0.2, 1.2) | 0.005 |
No | 0.6 (0.1, 1.1) | 0.012 |
Neoplasia | ||
Yes | 1.2 (0.8, 1.7) | < 0.001 |
No | 0.0 (-0.6, 0.6 | 0.903 |